Raymond James & Associates Increases Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Raymond James & Associates increased its position in Option Care Health, Inc. (NASDAQ:OPCH) by 6.3% in the 3rd quarter, Holdings Channel.com reports. The firm owned 85,279 shares of the company’s stock after buying an additional 5,049 shares during the quarter. Raymond James & Associates’ holdings in Option Care Health were worth $2,669,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Blue Trust Inc. raised its holdings in Option Care Health by 37.2% in the third quarter. Blue Trust Inc. now owns 4,022 shares of the company’s stock valued at $126,000 after acquiring an additional 1,091 shares in the last quarter. Trust Point Inc. increased its holdings in shares of Option Care Health by 2.6% in the 3rd quarter. Trust Point Inc. now owns 24,124 shares of the company’s stock worth $755,000 after acquiring an additional 622 shares during the period. Compass Wealth Management LLC increased its holdings in shares of Option Care Health by 75.5% in the 3rd quarter. Compass Wealth Management LLC now owns 193,128 shares of the company’s stock worth $6,045,000 after acquiring an additional 83,053 shares during the period. Creative Planning increased its holdings in shares of Option Care Health by 116.7% in the 3rd quarter. Creative Planning now owns 38,149 shares of the company’s stock worth $1,194,000 after acquiring an additional 20,546 shares during the period. Finally, UMB Bank n.a. increased its holdings in shares of Option Care Health by 937.5% in the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after acquiring an additional 750 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. JMP Securities increased their target price on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research report on Monday, September 30th. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their target price for the company from $38.00 to $27.00 in a research report on Monday. Barrington Research decreased their target price on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research report on Thursday, October 31st. Finally, Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and reduced their price objective for the company from $38.00 to $26.00 in a research report on Thursday, October 31st. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $30.83.

Option Care Health Price Performance

OPCH stock opened at $22.32 on Wednesday. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a one year low of $22.25 and a one year high of $34.63. The firm has a market capitalization of $3.80 billion, a PE ratio of 18.76, a P/E/G ratio of 1.90 and a beta of 1.32. The firm has a 50-day moving average of $30.14 and a two-hundred day moving average of $29.79.

Insider Transactions at Option Care Health

In other news, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the sale, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at $7,654,461.15. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now owns 21,339 shares in the company, valued at $663,429.51. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the transaction, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is owned by insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.